HSD17B13 and metabolic dysfunction-associated steatotic liver disease: Anstee's study compared the genetic profiles of NAFLD cases and controls by Genome‐Wide Association Study (GWAS) and identified that PNPLA3, TM6SF2, HSD17B13, and PYGO1 are risk factors for the full histological spectrum of NAFLD.61